Patients and visitors must continue to wear masks while at MSK, including people who are fully vaccinated. MSK is offering COVID-19 vaccines to all patients age 12 and over. To schedule or learn more, read this.
Simone Krebs, MD
Nuclear Medicine Physician
PET/CT; General Diagnostic and Therapeutic Nuclear Medicine
Nuclear Medicine - University of Freiburg, Germany; Molecular Imaging and Therapy - Memorial Sloan Kettering Cancer Center
Molecular Imaging and Therapy - Memorial Sloan Kettering Cancer Center
I am an American Board of Nuclear Medicine–certified physician-scientist, trained in molecular imaging and targeted radiotherapy in Germany and the United States. I have extensive experience in nuclear medicine and adoptive cell therapy. Additionally, I am well acquainted with interdisciplinary teamwork when it comes to disease management.
I have extensive training in translational and clinical research. My current research focuses on tracking adoptively transferred cells and evaluating theranostic approaches for neuroendocrine tumors, brain tumors, and other cancers. After completing my residency at Memorial Sloan Kettering, I received the Paul Calabresi Career Development Award for Clinical Oncology. With this grant, I can pursue an academic career as well as train further in translational and clinical research. Through my research I hope to contribute to the exciting field of radiotheranostics with a focus on T cell therapy, which is starting to show its great potential to improve outcomes for people with cancer.
Awards and Honors
K12 Paul Calabresi Career Development Award for Clinical Oncology, National Institutes of Health
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Visit PubMed for a full listing of Dr. Krebs’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Simone Krebs discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at email@example.com.